Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Aptevo Therapeutics Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Aptevo Therapeutics Inc. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. Across the 10 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 8 and Aptevo Therapeutics Inc. on 2.

Valuation

Metric APVO PPBT Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 n/m 9.40
P/B 0.25 0.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.15 0.66
EV/Sales (0.37) n/m 9.02
Earnings yield (4,659.10%) (3,843.12%) (32.88%)
Free cash flow yield (1,718.19%) (573.06%) (23.13%)

Profitability

Metric APVO PPBT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (110.67%) (51.96%)
Return on assets (186.29%) (100.91%) (46.06%)
Return on invested capital 0.00% (290.25%) 0.00%

Growth

Metric APVO PPBT Biotechnology median
Revenue growth (TTM) 92.94% — 6.76%
EPS growth (last fiscal year) 99.72% (10.14%) 29.88%
Revenue growth, 5-year CAGR (26.64%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 3.70 4.97
Net debt to EBITDA 0.83 0.35 1.01

Dividend

Metric APVO PPBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO PPBT Biotechnology median
Market cap 2.30m 2.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack